| Dr Albert Iban Soriano, MD | |
|
2025 Glenn Mitchell Dr, Virginia Beach, VA 23456-0178 | |
| (757) 507-4123 | |
| Not Available |
| Full Name | Dr Albert Iban Soriano |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 2025 Glenn Mitchell Dr, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942249073 | NPI | - | NPPES |
| 254949200 | Medicaid | FL | |
| 110195640 | Other | FL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101224316 (Virginia) | Primary |
| 207R00000X | Internal Medicine | ME75833 (Florida) | Secondary |
| 208M00000X | Hospitalist | 0101224316 (Virginia) | Secondary |
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the organization is in the process of working with market makers to move the trading of its common shares to the OTCBB quotation system. This comes about as a result of the recent completion of full financial audits for the years 2005 through 2009 and the filing of Form 10K with the U.S. Securities and Exchange Commission. BioElectronics is now a fully reporting company.
The potential of gene therapy has long been hampered by the risks associated with using viruses as vectors to deliver healthy genes, but a new University of Georgia study helps bring scientists closer to a safe and efficient gene delivery method that doesn't involve viruses.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.
Pharmaceutical Regulatory Services, Inc., a global provider of regulatory and pharmacovigilance support to the pharmaceutical, biotechnology and medical device industries, is pleased to announce the launch of GRID - Global Regulatory Intelligence Database.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
› Verified 6 days ago
| Entity Name | Martha Jefferson Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275720559 PECOS PAC ID: 5991889081 Enrollment ID: O20080228000055 |
News Archive
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the organization is in the process of working with market makers to move the trading of its common shares to the OTCBB quotation system. This comes about as a result of the recent completion of full financial audits for the years 2005 through 2009 and the filing of Form 10K with the U.S. Securities and Exchange Commission. BioElectronics is now a fully reporting company.
The potential of gene therapy has long been hampered by the risks associated with using viruses as vectors to deliver healthy genes, but a new University of Georgia study helps bring scientists closer to a safe and efficient gene delivery method that doesn't involve viruses.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.
Pharmaceutical Regulatory Services, Inc., a global provider of regulatory and pharmacovigilance support to the pharmaceutical, biotechnology and medical device industries, is pleased to announce the launch of GRID - Global Regulatory Intelligence Database.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Albert Iban Soriano, MD 2025 Glenn Mitchell Dr, Virginia Beach, VA 23456-0178 Ph: (757) 507-4123 | Dr Albert Iban Soriano, MD 2025 Glenn Mitchell Dr, Virginia Beach, VA 23456-0178 Ph: (757) 507-4123 |
News Archive
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the organization is in the process of working with market makers to move the trading of its common shares to the OTCBB quotation system. This comes about as a result of the recent completion of full financial audits for the years 2005 through 2009 and the filing of Form 10K with the U.S. Securities and Exchange Commission. BioElectronics is now a fully reporting company.
The potential of gene therapy has long been hampered by the risks associated with using viruses as vectors to deliver healthy genes, but a new University of Georgia study helps bring scientists closer to a safe and efficient gene delivery method that doesn't involve viruses.
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.
Pharmaceutical Regulatory Services, Inc., a global provider of regulatory and pharmacovigilance support to the pharmaceutical, biotechnology and medical device industries, is pleased to announce the launch of GRID - Global Regulatory Intelligence Database.
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
› Verified 6 days ago
Haidr Agha, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 First Colonial Rd, Ste 200, Virginia Beach, VA 23454 Phone: 757-623-0005 Fax: 757-389-5383 | |
Howard Courtenay Harrison Sr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 First Colonial Rd, Suite 101, Virginia Beach, VA 23454 Phone: 757-496-9020 Fax: 757-481-0638 | |
Vincent Lee, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5516 Virginia Beach Blvd, Virginia Beach, VA 23462 Phone: 757-473-3969 | |
Dr. Sue Beth Hudson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 Newtown Rd, Virginia Beach, VA 23462 Phone: 757-497-0606 Fax: 757-497-0411 | |
Dr. Rosario Devera Hipol, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Independence Cir Ste 102, Virginia Beach, VA 23455 Phone: 757-499-6395 Fax: 757-499-8026 | |
Dr. Jonah Anyaogu Ulu Ezieme, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-2323 Fax: 757-827-2255 | |
Dr. James Richard Miller, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 First Colonial Rd Ste 300, Virginia Beach, VA 23454 Phone: 757-395-1760 Fax: 757-756-5148 |